Acute management of Kawasaki disease

Progress in Pediatric Cardiology

Volumn 19, Issue 2 SPEC.ISS., 2004, Pages 129-135

  Dummer, Kirsten Bourke ^b   Newburger, Jane W ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Aspirin; Coronary artery abnormality; Intravenous immune globulin; Kawasaki disease; Management

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; CHICKENPOX VACCINE; CLOPIDOGREL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEXAMETHASONE; DIPHENHYDRAMINE; IBUPROFEN; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PENTOXIFYLLINE; PREDNISOLONE; PREDNISONE; PROPRANOLOL; SERINE PROTEINASE INHIBITOR; STEROID; ULINASTATIN; WARFARIN;

ANAPHYLAXIS; CARDIOVASCULAR RISK; CHILL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; EDEMA; FACE EDEMA; FEVER; FLUSHING; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOPATHOGENESIS; INFLAMMATION; LONG TERM CARE; LOW BACK PAIN; META ANALYSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NAUSEA; PLASMAPHERESIS; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING; VACCINATION; WHEEZING;

EID: 8444247048     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2004.08.006     Document Type: Article

References (51)

1. K.A. Taubert, A.H. Rowley, and S.T. Shulman Nationwide survey of Kawasaki disease and acute rheumatic fever J. Pediatr. 119 1991 279 282
2. K. Durongpisitkul, V.J. Gururaj, J.M. Park, and C.F. Martin The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment Pediatrics 96 1995 1057 1061
3. M. Nagashima, M. Matsushima, H. Matsuoka, A. Ogawa, and N. Okumura High-dose gammaglobulin therapy for Kawasaki disease J. Pediatr. 110 1987 710 712
4. G. Koren, E. Silverman, R. Sundel, P. Edney, J.W. Newburger, and J. Klein Decreased protein binding of salicylates in Kawasaki disease J. Pediatr. 118 1991 456 459
5. R.P. Sundel, J.W. Newburger, T. McGill, S.S. Cleveland, W.W. Miller, and B. Berry Sensorineural hearing loss and Kawasaki disease: a prospective study J. Pediatr. 117 1990 371 377
6. M. Takahashi, W. Mason, D. Thomas, and F. Sinatra Reye syndrome following Kawasaki syndrome confirmed by liver histopathology H. Kato Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22-25 Kawasaki disease 1995 Elsevier Science The Netherlands 436 444
7. J.H. Lee, H.Y. Hung, and F.Y. Huang Kawasaki disease with Reye syndrome: report of one case Acta Paediatr. Sin. 33 1992 67 71
8. D.Y. Leung, J.C. Burns, J.W. Newburger, and R.S. Geha Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin J. Clin. Invest. 79 1987 468 472
9. K. Furusho, T. Kamiya, H. Nakano, N. Kiyosawa, K. Shinomiya, and T Hayashidera High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1984 1055 1058
10. M. Basta, P. Kirshbom, M.M. Frank, and L.F. Fries Mechanism of therapeutic affect of high-dose intravenous immunoglobulin. Attentuation of acute, complement-dependent immume damage in a guinea pig model J. Clin. Invest. 84 6 1989 1974 1981
11. S.B. Clarkson, J.B. Bussel, R.P. Kimberly, J.E. Valinsky, R.L. Nachman, and J.C. Unkeless Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody N. Engl. J. Med. 314 19 1986 1236 1239
12. R.W. Finberg, J.W. Newburger, M.A. Mikati, A.H. Heller, and J.C. Burns Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood J. Pediatr. 120 1992 376 380
13. J.W. Newburger, M. Takahashi, J.C. Burns, A.S. Beiser, C.E. Duffy, and MP Glode The treatment of Kawasaki syndrome with intravenous gamma globulin N. Engl. J. Med. 315 1986 341 347
14. J.W. Newburger, M. Takahashi, A.S. Beiser, J.C. Burns, J. Bastian, and K.J. Chung A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N. Engl. J. Med. 324 1991 1633 1639
15. M. Terai, and S.T. Shulman Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose J. Pediatr. 131 1997 888 893
16. M. Marasini, G. Pongiglione, D. Gazzolo, A. Campelli, D. Ribaldone, and S. Caponnetto Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities Am. J. Cardiol. 68 1991 796 797
17. J.C. Burns, E.V. Capparelli, J.A. Brown, and J.W. Newburger Intravenous gamma globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group Pediatr. Infect. Dis. J. 17 1998 1144 1148
18. K. Hashino, M. Ishii, M. Iemura, T. Akagi, and H. Kato Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy Pediatr. Int. 43 2001 211 217
19. A.S. Beiser, M. Takahashi, A.L. Baker, R.P. Sundel, J.W. Newburger for the United States Multicenter Kawasaki Disease Study Group A predictive instrument for coronary artery aneurysms in Kawasaki disease Am. J. Cardiol. 81 1998 1116 1120
20. R.P. Sundel, J.C. Burns, A. Baker, A. Beiser, and J.W. Newburger Gamma globulin re-treatment in Kawasaki disease J. Pediatr. 123 4 1993 647 659
21. S.A. Misbah, and H.M. Chapel Adverse effects of intravenous immunoglobulin Drug Saf. 9 1993 254 262
22. T.G. Boyce, and P. Spearman Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome Pediatr. Infect. Dis. J. 17 1998 1054 1056
23. M. Nakagawa, N. Watanabe, M. Okuno, M. Kondo, H. Okagawa, and T. Taga Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease Am. J. Hematol. 63 2000 160 161
24. R.L. Comenzo, M.E. Malachowski, H.C. Meissner, D.R. Fulton, and E.M. Berkman Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease J. Pediatr. 120 1992 926 928
25. L.C. Schneider, and R. Geha Epidemiologic notes and reports outbreak of Hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993 - June 1994 MMWR 43 28 1994 505 509
26. E.D. Silverman, C. Huang, V. Rose, C. Boutin, J. Smallhorn, and B. McCrindle IVGG treatment of Kawasaki disease: are all brands equal? H. Kato Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22-25 Kawasaki disease 1995 Elsevier Science The Netherlands 301 304
27. E.A. Rosenfeld, S.T. Shulman, K.E. Corydon, W. Mason, M. Takahashi, and C. Kuroda Comparative safety and efficacy of two immune globulin products in Kawasaki disease J. Pediatr. 126 1995 1000 1003
28. Red Book 2003 Report of the Committee on Infectious Diseases 2003 American Academy of Pediatrics 395
29. H. Kato, S. Koike, and T. Yokoyama Kawasaki disease: effect of treatment on coronary artery Pediatrics 63 1979 175 179
30. Z. Nonaka, K. Maekawa, T. Okabe, Y. Eto, and M. Kubo Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki disease H. Kato Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22-25 Kawasaki disease 1995 Elsevier Science The Netherlands 328 331
31. M. Shinohara, K. Sone, T. Tomomasa, and A. Morikawa Corticosteroids in the treatment of the acute phase of Kawasaki disease J. Pediatr. 135 1999 465 469
32. R.P. Sundel, A.L. Baker, D.R. Fulton, and J.W. Newburger Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial J. Pediatr. 142 2003 611 616
33. S.T. Shulman Is there a role for corticosteroids in Kawasaki disease? J. Pediatr. 142 2003 601 603
34. Y. Kijima, T. Kamiya, A. Suzuki, O. Hirose, and H. Manabe A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease Jpn. Circ. J. 46 1982 1239 1242
35. A.S. Dajani, K.A. Taubert, M. Takahashi, F.Z. Bierman, M.D. Freed, and P Ferrieri Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 89 1994 916 922
36. D.A. Wright, J.W. Newburger, A. Baker, and R.P. Sundel Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids J. Pediatr. 128 1996 146 149
37. P.G. Dahlem, I.A. von Rosenstiel, J. Lam, and T.W. Kuijpers Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease Intensive Care Med. 25 1999 1137 1139
38. R.C. Dale, M.A. Saleem, S. Daw, and M.J. Dillon Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin J. Pediatr. 137 2000 723 726
39. K. Hashino, M. Ishii, M. Iemura, T. Akagi, and H. Kato Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy Pediatr. Int. 43 2001 211 217
40. E. Villain, J. Kachaner, D. Sidi, G. Blaysat, J.F. Piechaud, and E. Pedroni Trial of plasma exchange or intravenous gammaglobulin for the prevention of coronary aneuryms in Kawasaki disease Arch. Fr. Pediatr. 44 1987 79 83
41. N. Takagi, M. Kihara, S. Yamaguchi, K. Tamura, M. Yabana, and Y Tokita Plasma exchange in Kawasaki disease Lancet 346 1995 1307
42. M. Zaitsu, Y. Hamasaki, K. Tashiro, M. Matsuo, T. Ichimaru, and I Fujita Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease J. Infect. Dis. 181 2000 1101 1109
43. K. Nakatani, S. Takeshita, H. Tsujimoto, Y. Kawamura, and I. Sekine Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury J. Leukoc. Biol. 69 2001 241 247
44. S.P. Crouch, and J. Fletcher Effect of ingested pentoxifylline on neutrophil superoxide anion production Infect. Immun. 60 1992 4504 4509
45. S. Furukawa, T. Matsubara, Y. Umezawa, T. Motohashi, T. Ino, and K. Yabuta Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease Eur. J. Pediatr. 153 1994 663 667
46. C.A. Wallace, J.W. French, S.J. Kahn, and D.D. Sherry Initial intravenous gammaglobulin treatment failure in Kawasaki disease Pediatrics 105 2000 E78
47. M.S. Lee, S.Y. An, G.C. Jang, and D.S. Kim A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate Yonsei. Med. J. 43 2002 527 532
48. A.A. Schuna, and C. Megeff New drugs for the treatment of rheumatoid arthritis Am. J. Health Syst. Pharm. 57 2000 225 234
49. A. Kornbluth Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference Inflamm. Bowel Dis. 4 1998 328 329
50. P. Bartolucci, J. Ramanoelina, P. Cohen, A. Mahr, P. Godmer, and C Le Hello Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients Rheumatology (Oxford) 41 2002 1126 1132
51. S.P. Etheridge, L.Y. Tani, L.L. Minich, and J.R. Revenaugh Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease Cathet. Cardiovasc. Diagn. 45 1998 264 268